[Pharmacodynamics of piretanide in compromised kidney function. Dose response relationship and equipotency with furosemide].
Keller
E
E
Abteilung IV, Medizinische Universitätsklinik Freiburg.
Reetze-Bonorden
P
P
Rambauseck
M
M
Pooth
R
R
D000328:Adult; D000368:Aged; D004232:Diuretics / Q000008:administration & dosage / Q000493:pharmacokinetics*; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D005260:Female; D005665:Furosemide / Q000008:administration & dosage / Q000493:pharmacokinetics*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood* / Q000188:drug therapy; D007677:Kidney Function Tests; D008297:Male; D008657:Metabolic Clearance Rate; D008875:Middle Aged; D013449:Sulfonamides / Q000008:administration & dosage / Q000493:pharmacokinetics*; D014882:Water-Electrolyte Balance / Q000187:drug effects
D004232:Diuretics; D013449:Sulfonamides; D005665:Furosemide; C015451:piretanide
Pharmakodynamik von Piretanid bei eingeschränkter Nierenfunktion. Dosis-Wirkungs-Beziehung und Aquipotenz zu Furosemid.